Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- July 2022
has subject area
- 1103 Clinical Sciences (FoR)
- Administration, Oral (MeSH)
- Anticoagulants (MeSH)
- Blood Coagulation Tests (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Factor Xa Inhibitors (MeSH)
- Heparin, Low-Molecular-Weight (MeSH)
- Humans (MeSH)
- Pyrazoles (MeSH)
- Pyridones (MeSH)
- Rivaroxaban (MeSH)
published in
- Thrombosis Research Journal